Issue 4/2023
Content (8 Articles)
Application of physiologically based pharmacokinetics modeling in the research of small-molecule targeted anti-cancer drugs
Xiaowen Wang, Fang Chen, Nan Guo, Zhichun Gu, Houwen Lin, Xiaoqiang Xiang, Yufei Shi, Bing Han
Effect of massive ascites on ramucirumab pharmacokinetics in patients with gastrointestinal cancers: a population pharmacokinetic analysis
Takuya Kaneko, Kosuke Doki, Takeshi Yamada, Yoshiyuki Yamamoto, Toshikazu Moriwaki, Yoshiharu Suzuki, Masato Homma
Clinical implications and chemo-sensitivity of adjuvant chemotherapy in patients with poorly cohesive cells-gastric cancer
Jin Ho Baek, Byung Woog Kang, Hyojeung Kang, Miyeon Cho, Oh Kyoung Kwon, Ji Yeon Park, Ki Bum Park, An Na Seo, Jong Gwang Kim
Azithromycin inhibits glioblastoma angiogenesis in mice via inducing mitochondrial dysfunction and oxidative stress
Xiulan Zhang, Haibo Xu
Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma
Hidemi Nishi, Kunihito Gotoh, Yoshito Tomimaru, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Hidenori Takahashi, Masahiro Tanemura, Yuichiro Doki, Hidetoshi Eguchi
Effects of polymorphisms in pregnane X receptor and ABC transporters on afatinib in Japanese patients with non-small cell lung cancer: pharmacogenomic–pharmacokinetic and exposure–response analysis
Hayato Yokota, Kazuhiro Sato, Sho Sakamoto, Yuji Okuda, Mariko Asano, Masahide Takeda, Katsutoshi Nakayama, Masatomo Miura
Excessive vincristine exposure in a child being treated for acute lymphoblastic leukaemia with underlying Dubin–Johnson syndrome: a case report
Shelby Barnett, Aye Chan Nyein, Martin Galler, David Jamieson, Michelle Davies, Philip Connor, Gareth J. Veal